Wealth Enhancement Advisory Services, LLC Chroma Dex Corp. Transaction History
Wealth Enhancement Advisory Services, LLC
- $61.1 Billion
- Q3 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Chroma Dex Corp. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 13,470 shares of CDXC stock, worth $82,705. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,470
Previous 13,407
0.47%
Holding current value
$82,705
Previous $82,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CDXC
# of Institutions
174Shares Held
30.9MCall Options Held
121KPut Options Held
55.6K-
Vanguard Group Inc Valley Forge, PA4.02MShares$24.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.12MShares$19.1 Million0.0% of portfolio
-
Tieton Capital Management, LLC Yakima, WA1.65MShares$10.1 Million4.08% of portfolio
-
Arrowstreet Capital, Limited Partnership Boston, MA1.44MShares$8.82 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA1.3MShares$7.95 Million0.0% of portfolio
About ChromaDex Corp.
- Ticker CDXC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,350,896
- Market Cap $420M
- Description
- ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...